BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AMAG Pharmaceuticals, Inc. 

1100 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-498–3300 Fax: 617-499-3361


SEARCH JOBS



Founded in 1981, AMAG Pharmaceuticals is committed to improving the health outcomes of patients through the development and commercialization of specialty pharmaceutical products.

AMAG currently markets a therapeutic intravenous iron compound for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) and an oral rinse for the management of oral mucositis in the United States. To learn more about our products, click here. Along with driving organic growth of its lead product, AMAG intends to expand its portfolio with additional commercial-stage specialty pharmaceuticals. The company is seeking complementary products that leverage the company's commercial footprint and focus on hematology and oncology centers and hospital infusion centers.
Our iron oxide particles are composed of bioavailable iron that is easily absorbed by the body and incorporated into the body's iron stores. As a result, products using our core technology are well suited for use in intravenous iron replacement therapy.


 Key Statistics


Email: contactus@amagpharma.com
Ownership:

Web Site: AMAG Pharmaceuticals, Inc.
Employees: 51-200
Symbol: AMAG
 




Segment
Pharmaceuticals





 Company News
AMAG Pharmaceuticals, Inc. (AMAG) Announces Appointment Of John A. Fallon, M.D. To Board Of Directors 9/8/2014 8:40:40 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Present At Upcoming Investor Conferences 8/29/2014 8:50:41 AM
AMAG Pharmaceuticals, Inc. (AMAG) Appoints Robert Blood As Vice President Of Legal Affairs And Chief Compliance Officer 8/12/2014 7:48:34 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Participate In Jefferies Boston Healthcare Summit 8/4/2014 7:42:08 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Host Conference Call On July 29, 2014 At 8:00 A.M. ET To Discuss Financial Results For The Quarter And Six Months Ended June 30, 2014 7/25/2014 8:03:23 AM
AMAG Pharmaceuticals, Inc. (AMAG) Appoints Melissa Bradford Klug As Senior Vice President Of Business Development And Strategy 6/11/2014 6:39:36 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces Patent Term Extension For Ferumoxytol In The U.S. 6/6/2014 9:20:07 AM
AMAG Pharmaceuticals, Inc. (AMAG) To Present At The UBS Global Healthcare Conference 5/13/2014 8:54:56 AM
AMAG Pharmaceuticals, Inc. (AMAG) Release: Study Showing Effectiveness Of Mugard® For Management Of Oral Mucositis Featured In The Journal Cancer 4/28/2014 9:08:54 AM
AMAG Pharmaceuticals, Inc. (AMAG) Announces First Quarter 2014 Financial Results 4/24/2014 9:20:32 AM
12345678910...